HT-2157

Last updated
HT-2157
HT-2157 formula skeletal.svg
HT-2157 molecule spacefill.png
Clinical data
ATC code
  • none
Identifiers
  • 1-Phenyl-3-[3-(trifluoromethyl)phenyl]iminoindol-2-one
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
Chemical and physical data
Formula C21H13F3N2O
Molar mass 366.343 g·mol−1
3D model (JSmol)
  • c14ccccc4n(-c3ccccc3)c(=O)c1=N\c(c2)cccc2C(F)(F)F
  • InChI=1S/C21H13F3N2O/c22-21(23,24)14-7-6-8-15(13-14)25-19-17-11-4-5-12-18(17)26(20(19)27)16-9-2-1-3-10-16/h1-13H/b25-19+
  • Key:TXCGMRVPXUBHAL-NCELDCMTSA-N

HT-2157 (former development code SNAP-37889) is a drug which acts as a selective non-peptide antagonist for the receptor GAL-3, which is usually activated by the neuropeptide galanin. Blocking this receptor with HT-2157 produced increased serotonin release, [1] as well as producing antidepressant and anxiolytic effects in animal studies, [2] and it was also being researched for treatment of cognitive dysfunction. [3] All human clinical trials were terminated due to safety concerns however, and new GAL-3 antagonists are now being sought instead. [4]

References

  1. ↑ "pA2 Online". www.pa2online.org.
  2. ↑ Swanson CJ, Blackburn TP, Zhang X, Zheng K, Xu ZQ, Hökfelt T, et al. (November 2005). "Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299". Proceedings of the National Academy of Sciences of the United States of America. 102 (48): 17489–94. doi: 10.1073/pnas.0508970102 . PMC   1283534 . PMID   16287967.
  3. ↑ US 8277842,Kaplan AP,"Enteric-coated HT-2157 compositions and methods of their use",published January 20, 2012
  4. ↑ "Dart NeuroScience LLC -- Scientific Advisory Board". www.dartneuroscience.com.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.